1. Второй пересмотр рекомендаций ВНОК по профилактике, диагностике и лечению артериальной гипертензии // Кардиоваск. терапия и профилактика. - 2004. - Т. 3, № 3, ч. 1. - С. 105-120.
2. Российские рекомендации по диагностике и лечению стабильной стенокардии // Приложение к журн. Кардиоваск. терапия и профилактика. - 2004.
3. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр) // Сердечная недостаточность. - 2006. - Т. 8, № 2. - С. 1-35.
4. Collins R., Peto R., MacMahon S. et al. Blood pressure, stroke and coronary heart disease. Part II: Effects of short term-reductions of blood pressure - an overview of the unconfined randomized drug trials in an epidemiological context // Lancet. - 1990. - Vol. 335. - P. 827-838.
5. Wikstrand J., Warnold I., Tuomilehto J. et al. Metoprolol versus thiazide diuretics in hypertension. Morbidity results from MAPHY study // Hypertension. - 1991. - Vol. 17. - P. 570-588.
6. Viskin S., Kitzis I., Lev E. et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice // JACC. - 1995. - Vol. 25. - P. 1327-1332.
7. Berne C., Pollare T., Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors // Diabetes Care. - 1991. - Vol. 14 (suppl. 4). - P. 39-47.
8. Lithell H. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism // Diabetes Care. - 1991. - Vol. 14. - P. 203-209.
9. Reneland R., Alvares E., Andersson P.L. et al. Induction of insulin resistance by beta-blockade but not by ACE-inhibition: long-term treatment with atenolol or trandolapril // J. Hum. Hypertens. - 2000. - Vol. 14. - P. 175-180.
10. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Propranolol or HCTZ alone for the initial treatment of hypertension. IV. Effect on plasma glucose and glucose tolerance // Hypertension. - 1985. - Vol. 7. - P. 1008-1016.
11. The Working Group on Hypertension in diabetes: statement on hypertension in diabetes mellitus. Final report // Arch. Int. Med. - 1987. - Vol. 147. - P. 830-842.
12. Pool P.E., Seagren S.C., Salel A.F. Metabolic consequences of treating hypertension // Am. J. Hypertens. - 1991. - Vol. 4. - P. 494-502.
13. Weidmann P., Feffier C., Saxenhofer H. et al. Serum lipoproteins during treatment with antihypertensive drugs // Drugs. - 1988. - Vol. 35 (suppl. 6). - P. 118-134.
14. Pepine C.J., Handberg E.M., Cooper-DeHoff R.M. et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease the international verapamil SR/trandolapril study (INVEST): a randomized controlled trial // JAMA. - 2003. - Vol. 290, № 21. - P. 2805-2816.
15. The ALLHAT Officers and Coordinators Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic // JAMA. - 2002. - Vol. 288. - P. 2981-2997.
16. Dahlof B., Devereux R.B., Kjeldsen S.E. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol // Lancet. - 2002. - Vol. 359. - P. 995-1003.
17. Elliot W.J., Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis // Lancet. - 2007. - Vol. 369. - P. 210-207.
18. Beevers D.G. The end of beta-blockers for uncomplicated hypertension? // Lancet. - 2005. - Vol. 366. - P. 1510-1512.
19. Hypertension: management of hypertension in adults in primary care. NICE. / BHS. - 2006. URL: www.nice.org.uk/CGO34.GL
20. Рекомендации по диагностике и лечению артериальной гипертонии (второй пересмотр) // Кардиоваск. терапия и профилактика. - 2008. - № 6 (Приложение).
